Literature DB >> 1536915

Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study.

M Eriksson1, B Hållberg.   

Abstract

In a population-based case-control study in Sweden on multiple myeloma, the occurrence of different diseases in relatives, particularly hematologic malignancies and different types of cancer, was investigated. Through a questionnaire mailed to all living subjects, i.e. cases and controls, and to the next-of-kin for deceased subjects, information was obtained on malignant and certain other diseases among relatives. All malignant diseases reported among first-degree relatives were verified, if possible, through parochial authorities and the Swedish Cancer Register. In total, data from 239 cases with myeloma and 220 controls were analyzed. An increased risk was found for persons with first-degree relatives with hematologic malignancies (relative risk [RR] = 2.36, 90 percent confidence interval [CI ) = 0.90-6.15), and also with multiple myeloma specifically (RR = 5.64, CI = 1.16-27.51). An increased risk also was seen if the close relatives had experienced another tumor disease (RR = 1.21, CI = 0.86-1.71). Particularly, occurrence of prostatic cancer (RR = 3.11, CI = 1.25-7.71) or brain tumor (RR = 6.61, CI = 1.42-30.67) in relatives increased the risk for multiple myeloma.

Entities:  

Mesh:

Year:  1992        PMID: 1536915     DOI: 10.1007/bf00051914

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  17 in total

1.  Estimability and estimation in case-referent studies.

Authors:  O Miettinen
Journal:  Am J Epidemiol       Date:  1976-02       Impact factor: 4.897

2.  Familial aggregation of multiple myeloma and central nervous system diseases.

Authors:  S Grufferman; H J Cohen; E S Delzell; M C Morrison; S C Schold; J O Moore
Journal:  J Am Geriatr Soc       Date:  1989-04       Impact factor: 5.562

3.  Familial malignant blood disease in the country of Jämtland, Sweden.

Authors:  M Eriksson; I Bergström
Journal:  Eur J Haematol       Date:  1987-03       Impact factor: 2.997

4.  Multiple myeloma in two brothers. An immunochemical and immunogenetic familial study.

Authors:  B Grosbois; M Gueguen; R Fauchet; H Lebouc; A Guenot; F Lancelin; R Lauvin; R Leblay; B Genetet
Journal:  Cancer       Date:  1986-12-01       Impact factor: 6.860

5.  Multiple myeloma in three siblings.

Authors:  L J Horwitz; R N Levy; F Rosner
Journal:  Arch Intern Med       Date:  1985-08

6.  Multiple myeloma, acute leukemia, and Hodgkin's disease. Occurrence in three of four family members.

Authors:  R A Kyle; E S Henderson; V L Randolph; W R Budge
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

7.  Multiple myeloma and family history of cancer. A case-control study.

Authors:  C C Bourguet; S Grufferman; E Delzell; E R DeLong; H J Cohen
Journal:  Cancer       Date:  1985-10-15       Impact factor: 6.860

8.  Concurrent familial myeloma in Northern Ireland.

Authors:  A P McCrea; T C Morris
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

9.  Family history of autoimmune disorders and cancer in multiple myeloma.

Authors:  M S Linet; J K Mclaughlin; S D Harlow; J F Fraumeni
Journal:  Int J Epidemiol       Date:  1988-09       Impact factor: 7.196

10.  [Familial myeloma. Apropos of a case].

Authors:  D Hubert; M Thomas; M Krulik; A de Gramont; P Brissaud; A Sirinelli; J Debray
Journal:  Rev Med Interne       Date:  1985-10       Impact factor: 0.728

View more
  16 in total

Review 1.  Inherited genetic susceptibility to multiple myeloma.

Authors:  G J Morgan; D C Johnson; N Weinhold; H Goldschmidt; O Landgren; H T Lynch; K Hemminki; R S Houlston
Journal:  Leukemia       Date:  2013-11-19       Impact factor: 11.528

Review 2.  Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Jill Koshiol; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-07       Impact factor: 9.941

3.  The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study.

Authors:  Gudbjörg Jonsdottir; Sigrún H Lund; Magnus Björkholm; Ingemar Turesson; Malin Hultcrantz; Anna Porwit; Yogesh S Jethava; Ola Landgren; Sigurdur Y Kristinsson
Journal:  Blood Adv       Date:  2017-11-22

Review 4.  Cancer in Jews: introduction and overview.

Authors:  Henry T Lynch; Wendy S Rubinstein; Gershon Y Locker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

5.  Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.

Authors:  Celine M Vachon; Robert A Kyle; Terry M Therneau; Barbara J Foreman; Dirk R Larson; Colin L Colby; Tara K Phelps; Angela Dispenzieri; Shaji K Kumar; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

6.  Familial myeloma.

Authors:  Henry T Lynch; Kelly Ferrara; Bart Barlogie; Elizabeth A Coleman; Jane F Lynch; Dennis Weisenburger; Warren Sanger; Patrice Watson; Henry Nipper; Vinetta Witt; Stephan Thomé
Journal:  N Engl J Med       Date:  2008-07-10       Impact factor: 91.245

7.  Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium.

Authors:  Leah H Schinasi; Elizabeth E Brown; Nicola J Camp; Sophia S Wang; Jonathan N Hofmann; Brian C Chiu; Lucia Miligi; Laura E Beane Freeman; Silvia de Sanjose; Leslie Bernstein; Alain Monnereau; Jacqueline Clavel; Guido J Tricot; Djordje Atanackovic; Pierluigi Cocco; Laurent Orsi; James A Dosman; John R McLaughlin; Mark P Purdue; Wendy Cozen; John J Spinelli; Anneclaire J de Roos
Journal:  Br J Haematol       Date:  2016-06-22       Impact factor: 6.998

8.  Inherited predisposition to multiple myeloma.

Authors:  Divya T Koura; Amelia A Langston
Journal:  Ther Adv Hematol       Date:  2013-08

9.  Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Lynn R Goldin; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

10.  Familial multiple myeloma: report on two families and discussion of screening options.

Authors:  Erica H Gerkes; Mirjam M de Jong; Rolf H Sijmons; Edo Vellenga
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.